Dr. Schein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2805 SE Dune Dr
Stuart, FL 34996Phone+1 610-527-4605
Summary
- Basic and Clinical Pharmacology, therapeutic development of anti cancer agents, cancer clinical trials, chemical-induced diabetes, predictive value of animal models of human toxicity
Education & Training
- University of Oxfordno degree, Metabolic biochemistry , 1970 - 1971
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1968 - 1971
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1965 - 1966
- SUNY Upstate Medical UniversityClass of 1965
- Rutgers CollegeAB, 1957 - 1961
Certifications & Licensure
- PA State Medical License 1984 - 2026
- DC State Medical License 1974 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Honorary Doctorate of Science Rutgers University, 2006
- Distinguished Alumnus Award Upstate Medical University, 2005
- Distinguished Hall of Aiumni Award Rutgers University, 2005
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsChemotherapy of large intestinal carcinoma. Current results and future prospects.Philip S. Schein, Daniel L. Kisner, John S. Macdonald
Cancer. 2006-06-28 - 19 citationsBarriers to efficient development of cancer therapeutics.Philip S. Schein, Barbara Scheffler
Clinical Cancer Research. 2006-06-01 - 1 citationsThe role of the FDA in the national cancer program: friend or foe?Philip S. Schein, Barbara Scheffler, Stephen K. Carter
The Oncologist. 2003-12-01
Journal Articles
- The Case for a New National Program for the Development of Cancer TherapeuticsSchein, P.S., J. Clin. Oncology, 1/1/2001
- Phase II Study of Trimetrexate, Fluorouracil, and Leucovorin for Advanced Colorectal CancerBlanke, C.D., Kasimis, B., Schein, P., Capizzi, R., Kurman, M, Journal of Clinical Oncology, 1/1/1997
- Use of Amifostine in Bone Marrow PurgingCagnoni, P.J.; Jones, R.B.; Scott I.B.; Ross, M.; Hami, L.; Franklin, W.A.; Capizzi, R.L.; Schein, P.S.; Shpall, E.J., Seminars in Oncology, 1/1/1996
- Join now to see all
Books/Book Chapters
Lectures
- Commencement AddressRutgers/Camden School of Business - 1/1/1997
- Class of 1960 Scholars LectureWilliams College, Williamstown, MA - 1/1/1994
- Clinica Independencia ConferenceBuenos Aires, Argentina - 1/1/1993
- Join now to see all
Press Mentions
- CASIS Announces Joseph Vockley as President and Executive DirectorJune 29th, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: